Oncodesign Precision Medicine
VerifiedConducts research and development work on new therapeutic and diagnostic tools.
Launch date
Employees
Market cap
€99.7m
Net debt
(€2.6m)
Enterprise valuation
$113m (Public information from Dec 2022)
Share price
€14.42 AlONC.PA
Company register number 892226762
Dijon Bourgogne-Franche-Comté (HQ)
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 40 % | 43 % | 30 % | (4 %) | 28 % | 63 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (20 %) | 21 % | (10 %) | 12 % | 16 % | (3 %) | 6 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | 36 % | (15 %) | 4 % | 8 % | (3 %) | 4 % |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 50 % | 71 % | 100 % | 77 % | 120 % | - | - |
Source: Dealroom estimates
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor | $0.0 | round |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| investor investor investor | $0.0 | round | |
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
* | €1.7m | Grant | |
| Total Funding | 000k | ||
Related Content
Recent News about Oncodesign Precision Medicine
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.